Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Magnesium aspartate (magnesium 10mmol) oral powder sachets
0905013A0AAAHAH
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | 14,547 |
|
Magnesium aspartate (magnesium 10mmol) gran for soln sachets
0905013A0AAAEAE
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | 513 |
|
Magnesium aspartate (magnesium 10mmol) oral pdr sach SF
0905013A0AAAJAJ
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | 77 |
|
Magnesium aspartate (magnesium 2.5mmol) tablets
0905013A0AAAFAF
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | No data available |
|
Magnesium aspartate (magnesium 5mmol) oral powder sachets
0905013A0AAAGAG
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | No data available |
|
Magnesium aspartate (magnesium 7.5mmol) efferv tab SF
0905013A0AAAIAI
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.